8 completed, 3 withdrawn, 2 not yet recruiting, 2 unknown. 17 Phase 4.
| Phase | Trials | Status |
|---|---|---|
| Phase 4 | 17 | Completed 8, Withdrawn 3, Not yet recruiting 2, Unknown 2, Recruiting 1, Terminated 1 |
Follow Sweat Gland Diseases: new trials by email Literature Review of Sweat Gland Diseases trials Research Report on Sweat Gland Diseases
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Study of Efficacy and Safety of Secukinumab in Chinese Adult Patients With Moderate to Severe Hidradenitis Suppurativa Secukinumab - Hidradenitis Suppurativa (HS) | Phase 4 | Recruiting | Novartis Pharmaceuticals | 36 | 2026-06-01 | 2026-09-09 |
| A Single-center, Prospective, Self-controlled, Observational Real-world Study of the Efficacy and Safety of Anti-IL-17A/F Monoclonal Antibody Combined With Non-ablative Dot Laser for the Treatment of Mild to Moderate Hidradenitis Suppurativa IL-17A/F mAb + NAFL - Hidradenitis Suppurativa (HS) | Phase 4 | Not yet recruiting | Second Affiliated Hospital, Zhejiang University, School of Medicine | 50 | 2026-04-01 | 2026-04-28 |
| Comparison of the Clinical Efficacy and Safety of Topical and Subcutaneous Injection of Secukinumab in HS Topical injection of Secukinmab, Subcutaneous injection of Secukinumab - Hidradenitis Suppurativa (HS), Hidradenitis Suppurativa (Acne Inversa) | Phase 4 | Not yet recruiting | Peking Union Medical College | 30 | 2025-12-01 | 2025-12-03 |
| Botulinum Toxin-A for Hidradenitis Suppurativa Normal saline, Botulinum toxin type A - Hidradenitis Suppurativa, Hidradenitis Suppurativa \(HS\) | Phase 4 | Withdrawn | Yale University | 2025-01-01 | 2025-12-16 | |
| Comparative Efficacy of Apremilast and Acitretin in Moderate-to-Severe Hidradenitis Suppurativa Apremilast, Acitretin - Hidradenitis Suppurativa | Phase 4 | Completed | Hayat Abad Medical Complex, Peshawar | 70 | 2024-12-22 | 2026-07-16 |
| A Randomized, Controlled Trial Comparing the Use of a Biodegradable Temporizing Matrix to Cadaver Skin in the Reconstruction of Hidradenitis Suppurativa Excisions NovoSorb® BTM, Human Cadaveric Allograft - Hidradenitis Suppurativa | Phase 4 | Unknown | Joseph M. Still Research Foundation, Inc. | 10 | 2022-10-01 | 2023-09-28 |
| Optimizing Intralesional Triamcinolone Dosing for Hidradenitis Suppurativa Intralesional Triamcinolone 10 mg/mL, Intralesional Triamcinolone 20 mg/mL, Intralesional Triamcinolone 40 mg/mL - Hidradenitis Suppurativa | Phase 4 | Terminated | Montefiore Medical Center | 11 | 2022-01-24 | 2023-11-13 |
| Spironolactone for Hidradenitis Suppurativa Spironolactone 50 MG, Spironolactone 100mg, Spironolactone 200 mg - Hidradenitis Suppurativa | Phase 4 | Withdrawn | Medical University of South Carolina | 2020-09-21 | 2024-09-19 | |
| Hidradenitis Suppurativa Patient Experience With Humira Treatment Electronic Reporting, Adalimumab - Hidradenitis Suppurativa | Phase 4 | Withdrawn | Wake Forest University Health Sciences | 2020-08-20 | 2022-09-29 | |
| Cost-effectiveness of Adalimumab and Surgery vs Adalimumab in HS Wide Excision, Adalimumab Injection - Hidradenitis Suppurativa | Phase 4 | Unknown | Erasmus Medical Center | 128 | 2018-07-31 | 2019-02-08 |
| Hyperhydrosis Treatment Using Botulinum Toxin botulinum toxin A - Hyperhidrosis | Phase 4 | Completed | St Joseph University, Beirut, Lebanon | 15 | 2018-05-01 | 2019-01-25 |
| Safety and Efficacy of Adalimumab (Humira) for Hidradenitis Suppurativa (HS) Peri-Surgically Placebo, Adalimumab - Hidradenitis Suppurativa (HS) | Phase 4 | Completed | AbbVie | 206 | 2016-07-18 | 2020-05-14 |
| Use of Oxybutynin for Treating Hyperhidrosis: A Placebo-control Study Oxybutynin, placebo - Hyperhidrosis | Phase 4 | Completed | University of Sao Paulo | 50 | 2010-12-01 | 2011-09-22 |
| VASER Treatment of Axillary Hyperhidrosis/Bromidrosis VASER - Axillary Hyperhidrosis | Phase 4 | Completed | Commons Aesthetic Plastic Surgery | 13 | 2007-04-01 | 2008-09-19 |
| Excessive Sweating Caused by Antidepressants: Measurement and Treatment With Terazosin terazosin - Hyperhidrosis | Phase 4 | Completed | Thomas Jefferson University | 23 | 2007-03-01 | 2016-08-25 |
| A Study Using Botulinum Toxin Type A in Adolescents With Axillary Hyperhidrosis Botulinum Toxin Type A - Hyperhidrosis | Phase 4 | Completed | Allergan | 144 | 2005-08-01 | 2008-09-29 |
| A Study Using Botulinum Toxin Type A in Patients With Axillary Hyperhidrosis Botulinum Toxin Type A - Hyperhidrosis | Phase 4 | Completed | Allergan | 424 | 2003-11-01 | 2008-09-29 |
Hidradenitis Suppurativa (11) · Hyperhidrosis (6) · Body Odor (1) · Depressive Disorder (1) · Pain (1)
Skin Diseases (17) · Skin and Connective Tissue Diseases (17) · Bacterial Infections (11) · Bacterial Infections and Mycoses (11) · Hidradenitis (11) · Infections (11) · Skin Diseases, Bacterial (11) · Skin Diseases, Infectious (11) · Suppuration (11) · Pathological Conditions, Signs and Symptoms (2) · Signs and Symptoms (2) · Mental Disorders (1) · Mood Disorders (1) · Neurologic Manifestations (1)
Botulinum Toxins, Type A (4) · Adalimumab (3) · Acitretin (1) · Canrenoic Acid (1) · Saline Solution (1) · Spironolactone (1) · Terazosin (1) · apremilast (1) · oxybutynin (1) · secukinumab (1)
Allergan (2) · AbbVie (1) · Commons Aesthetic Plastic Surgery (1) · Erasmus Medical Center (1) · Hayat Abad Medical Complex, Peshawar (1) · Joseph M. Still Research Foundation, Inc. (1) · Medical University of South Carolina (1) · Montefiore Medical Center (1) · Novartis Pharmaceuticals (1) · Peking Union Medical College (1) · Second Affiliated Hospital, Zhejiang University, School of Medicine (1) · St Joseph University, Beirut, Lebanon (1) · Thomas Jefferson University (1) · University of Sao Paulo (1) · Wake Forest University Health Sciences (1)
United States (9) · China (3) · Canada (2) · Germany (2) · Netherlands (2) · Sweden (2) · United Kingdom (2) · Belgium (1) · Brazil (1) · Colombia (1) · Czechia (1) · Denmark (1) · France (1) · Greece (1) · Ireland (1)
Dirk Elston, MD (1) · Martijn van Doorn, MD, PhD (1) · Rajnish Mago, MD (1) · Rita O Pichardo, MD (1) · Rummana Aslam, MD (1) · Steven R Cohen, MD, MPH (1) · Zaheed Hassan, MD (1)
PMID 23247938, PMID 23638448, PMID 24807602, PMID 25640693, PMID 26059781, PMID 27518661, PMID 31604104, PMID 32460374, PMID 34406349, PMID 34510518, PMID 36746171, PMID 38770982, PMID 39032087, PMID 39862870
2015 (1)